AKBA ▲ +3.3% - Akebia Therapeutics, Inc. $AKBA - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Akebia Therapeutics announced inducement grants to employees under Nasdaq's Rule 5635(c)(4), a standard equity compensation practice for new hires. The stock rose 3.3% on the news, though inducement grants themselves are routine corporate actions that typically do not materially move share price on their own. 01-SEP-2026 04:07 PM ET